Jost-Julian R.
- Country
- Germany
- Department
- Klinik und Poliklinik für Neurologie
Research Overview
- Efficacy and Safety of NIO752 in Participants with Progressive Supranuclear Palsy Richardson Syndrome: A Phase III Randomized, Placebo-Controlled Study
- Phase 2 Randomized, Double-blind, Placebo-controlled Study of Emrusolmin in Adult Patients with Multiple System Atrophy
- Phase 2 Randomized, Double-Blind, Placebo-Controlled Study of FNP-223 in Progressive Supranuclear Palsy to Evaluate Efficacy and Safety
Data & Insights
Has run more than one trial at 34 of 74 partner sites.
Specializations
Neurodegenerative Disorders
This investigator specializes in researching therapeutic approaches for Multiple System Atrophy (MSA), a progressive neurodegenerative disorder that affects multiple areas of the nervous system.
- Disease Progression Assessment
- Therapeutic Intervention Evaluation
- Movement Disorder Management
The research focus includes evaluating novel therapeutic compounds for MSA treatment and monitoring disease progression through specialized assessment tools.
Clinical Assessment
The investigator employs comprehensive clinical assessment methodologies, particularly focusing on the Unified Multiple System Atrophy Rating Scale (UMSARS) to evaluate treatment efficacy.
- Functional Assessment Protocols
- Patient Monitoring Systems
- Treatment Response Evaluation
Their work involves systematic evaluation of patient responses to therapeutic interventions using standardized rating scales.
Treatment Development
The investigator is involved in advancing novel therapeutic approaches for MSA through systematic clinical evaluation of experimental treatments.
- Oral Therapeutic Development
- Safety Assessment
- Long-term Treatment Effects
Research activities focus on evaluating the safety, tolerability, and efficacy of new therapeutic compounds for MSA treatment.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.